SK Capital Partners, a New York City-based private investment firm, has signed a definitive agreement to create IBA Molecular Imaging, a jointly-owned new company derived from the radiopharmaceutical division of IBA (Ion Beam Applications).

Citing significant variations in pediatric radiopharmaceutical doses and package inserts lacking pediatric doses, the authors of an article appearing in the November issue of Radiology indicated recently approved consensus guidelines for pediatric administered radiopharmaceutical doses may help solve the problem. 

Neoprobe, a developer of oncology surgical and diagnostic products, has submitted a new drug application for Lymphoseek (tilmanocept) to the FDA.

GE Healthcare and Rapidscan Pharma Solutions have introduced regadenoson, marketed as Rapiscan, to facilitate myocardial perfusion scintigraphy (MPS) to diagnose coronary artery disease for patients unable to exercise.